Related Experiment Video
Updated: Sep 13, 2025

08:21
Curation of Computational Chemical Libraries Demonstrated with Alpha-Amino Acids
Published on: April 13, 2022
2.7K
Benchmarking 3D Structure-Based Molecule Generators
Natasha Sanjrani1,2, Damien E Coupry1, Peter Pogány1
1Department of Cheminformatics, Research Technologies, GSK, Gunnels Wood Road, Stevenage SG1 2NY, U.K.
Journal of Chemical Information and Modeling
|July 25, 2025
Summary
Deep learning generators struggle with structural validity, while combinatorial methods are slow. A new benchmark highlights areas for improvement in structure-based drug design generators.
Area of Science:
- * Computational chemistry and cheminformatics.
- * Artificial intelligence in drug discovery.
- * Molecular modeling and simulation.
Background:
- * Evaluating generative models for drug design is crucial.
- * Existing methods for generating 3D molecules have limitations.
- * Protein-ligand interactions and conformations are key drug design targets.
Purpose of the Study:
- * To benchmark 3D combinatorial and deep learning generators.
- * To assess their ability to recreate protein-ligand interactions and conformations.
- * To identify strengths and weaknesses of different generative approaches.
Main Methods:
- * Developed a novel benchmark using the BindingMOAD dataset.
- * Evaluated sequential graph neural networks (Pocket2Mol, PocketFlow), diffusion models (DiffSBDD, MolSnapper), and genetic algorithms (AutoGrow4, LigBuilderV3).
- * Assessed structural validity, 3D ligand conformations, and interaction recreation.
Main Results:
- * Deep learning models failed to generate structurally valid molecules and conformations.
- * Combinatorial methods were slow and produced molecules failing 2D filters.
- * Identified specific limitations of both deep learning and combinatorial approaches.
Conclusions:
- * Deep learning generators need improved focus on structural validity and interaction accuracy.
- * Combinatorial generators require optimization for speed and filter compliance.
- * The benchmark provides a framework for advancing structure-based drug design generators.

